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Abstract Previous studies have demonstrated that Fas-trig-
gered activation of e¡ector caspases and subsequent nuclear
apoptosis either is mitochondria-independent (type I cells) or
relies on mitochondrial ampli¢cation of the initial stimulus
(type II cells). We show herein that Bcl-2 overexpression in a
prototypic type I cell line (SKW6.4) promotes mitochondrial
generation of ATP and blocks Fas-triggered plasma membrane
externalization of phosphatidylserine (PS). Moreover, overex-
pression of Bcl-2 attenuates macrophage engulfment of Fas-trig-
gered cells. Fas-mediated DNA fragmentation, on the other
hand, remains una¡ected in SKW6.4-bcl-2 cells. These studies
thus demonstrate that PS externalization and clearance of cell
corpses are mitochondria-dependent events, and show that these
events can be dissociated from other features of the apoptotic
program, in Fas type I cells.
0 2003 Federation of European Biochemical Societies. Pub-
lished by Elsevier Science B.V. All rights reserved.
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1. Introduction
The rapid engulfment of apoptotic cells by neighboring
macrophages serves to preclude the release of noxious cellular
constituents and the tissue scarring that would otherwise en-
sue [1]. Previous studies have shown that the externalization
of phosphatidylserine (PS) [2] and its concomitant oxidation
[3] is critical for macrophage recognition and uptake of e¡ete
cells. While the apoptotic redistribution of PS has been dem-
onstrated to require extracellular Ca2þ [4] and the activation
of caspases [5^7], the downstream signaling events have re-
mained poorly understood. We have recently provided evi-
dence that the decline of intracellular ATP and inhibition of
the ATP-dependent aminophospholipid translocase may gov-
ern the egress of PS during Fas-triggered apoptosis [8]. To
further elucidate the mechanism underlying PS externaliza-
tion, we focused in the present study on Fas-triggered apo-
ptosis in the prototypic type I cell line, SKW6.4. Type I cells
are thought to be mitochondria-independent insofar as Bcl-2
fails to abrogate nuclear apoptotic changes upon Fas ligation
[9]. By contrast, cell death and the activation of caspases in
type II cells were shown to be critically dependent on mito-
chondrial signaling. Caspase-8-mediated cleavage of cytosolic
Bid serves as a link between death receptor activation at the
plasma membrane and mitochondrial events; upon cleavage,
truncated Bid translocates to mitochondria and initiates the
cytochrome c-dependent activation of caspases downstream of
these organelles [10,11]. The fact that hepatocytes derived
from Bid-de¢cient mice are Fas-resistant and the observation
that these animals are protected from anti-Fas antibody-in-
duced hepatic injury [12] suggest that the type II phenotype
can be recapitulated in vivo.
In the present study, we demonstrate that overexpression of
Bcl-2 blocks PS exposure in Fas type I cells. Moreover, the
externalization of PS was found to be dissociated from other
indices of apoptosis, including the activation of caspase-3-like
enzymes and the induction of nuclear apoptotic changes. Our
data also show that Bcl-2 overexpression attenuates clearance
of Fas-triggered type I cells by two classes of macrophages,
thus suggesting that execution of cell death and clearance of
cell corpses are independently regulated processes.
2. Materials and methods
2.1. Reagents and cell culture
Anti-Fas monoclonal antibodies (clone CH-11) were purchased
from Medical and Biological Laboratories (Nagoya, Japan). Ben-
zyloxycarbonyl-Val-Ala-Asp-£uoromethylketone zVAD-fmk and
DEVD-AMC were obtained from Enzyme Systems Products (Dublin,
CA, USA) and Peptide Institute (Osaka, Japan), respectively. Oligo-
mycin was from Sigma (St. Louis, MO, USA). The human B cell line
SKW6.4 (European Collection of Cell Cultures, Salisbury, UK) was
cultured in the high glucose version of Dulbecco’s modi¢ed Eagle’s
medium (DMEM) (Life Technologies) supplemented with 10% heat-
inactivated fetal bovine serum (FBS), 50 WM 2-mercaptoethanol,
100 W/ml penicillin and 100 mg/ml streptomycin (Life Technologies),
in a humidi¢ed atmosphere of 5% CO2 at 37‡C. The SKW6.4-bcl-2
and SKW6.4-neo cell lines, stably transfected with retroviral vectors
co-expressing the human bcl-2 cDNA and a neomycin resistance gene,
and a control neo construct, respectively, were kindly provided by
Drs. Andreas Strasser and Lorraine O’Reilly (Melbourne, Australia)
and were cultured as previously described [13]. The human monocytic
cell line THP-1 (European Collection of Cell Cultures) was main-
tained in RPMI 1640 medium (Life Technologies) supplemented
with 10% heat-inactivated FBS, 2 mM glutamine, 100 U/ml penicillin,
100 Wg/ml streptomycin, 1 mM Na-pyruvate, and 50 WM 2-mercapto-
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ethanol. To induce di¡erentiation into macrophage-like cells, 5U105
cells were stimulated with phorbol 12-myristate 13-acetate (Sigma) at
150 nM for 3 days. The murine macrophage cell line J774A.1 (Euro-
pean Collection of Cell Cultures) was cultured in DMEM (Life Tech-
nologies) supplemented with 10% heat-inactivated FBS, 100 U/ml
penicillin, 100 Wg/ml streptomycin, and 50 Wg/ml gentamicin sulfate.
2.2. Western blot
Cell lysates were resolved by 12% sodium dodecyl sulfate^polyac-
rylamide gel electrophoresis at 130 V and electroblotted to nitrocellu-
lose membranes for 2 h at 100 V. Membranes were blocked for 1 h
with 5% non-fat milk in phosphate-bu¡ered saline (PBS) at room
temperature and subsequently probed overnight with monoclonal
antibodies directed against Bcl-2 (Dako, Glostrup, Denmark) or poly-
clonal antibodies directed against glyceraldehyde-3-phosphate de-
hydrogenase (G3PDH) (Trevigen, Gaithersburg, MD, USA). After
washing, membranes were incubated with a horseradish peroxidase-
conjugated secondary antibody (Pierce, Rockford, IL, USA) and
bound antibody was visualized by enhanced chemiluminescence
(Amersham, Buckinghamshire, UK). Densitometric analysis was per-
formed using a Fuji LAS 1000 Plus densitometer (Fuji, Stockholm,
Sweden).
2.3. Mitochondrial transmembrane potential
Loss of mitochondrial transmembrane potential (vim) was detected
using the cationic £uorescent probe tetramethylrhodamine ethyl ester
(TMRE) (Molecular Probes, Leiden, The Netherlands). Brie£y,
0.5U106 cells were incubated with 25 nM TMRE at 37‡C for
20 min. Cells were then pelleted, washed once in PBS and resuspended
in HEPES bu¡er (10 mM HEPES, 150 mM NaCl, 5 mM KCl, 1 mM
MgCl2 and 1.8 mM CaCl2) containing 25 nM TMRE. Flow cytomet-
ric analysis was performed on a FACScan (Becton Dickinson, San
Jose, CA, USA) using the CellQuest software (Becton Dickinson).
2.4. ATP determination
The concentration of intracellular ATP was determined using the
luciferase-based ATP Bioluminescence Assay Kit CLS II (Boehringer
Mannheim, Mannheim, Germany) as previously described [8]. Data
are presented as nM ATP based on an ATP standard curve.
2.5. PS exposure
PS exposure was determined by £ow cytometric detection of annex-
in V using the protocol outlined in the annexin V-FITC apoptosis
detection kit (Pharmingen, BD Biosciences, San Diego, CA, USA).
Cells were washed and resuspended in HEPES bu¡er containing an-
nexin V-FITC and propidium iodide (100 Wg/ml) prior to analysis on
a FACScan £ow cytometer (Becton Dickinson). Ten thousand events
were collected and analyzed using the CellQuest software. Low-£uo-
rescence debris and necrotic (propidium iodide-positive) cells were
gated out prior to analysis.
2.6. Caspase activity
The measurement of DEVD-AMC cleavage, indicative of caspase-
3-like enzyme activity, was performed in a £uorometric assay as pre-
viously described [14]. Cleavage of the £uorogenic substrate was
monitored by AMC liberation in a Fluoroscan II plate reader (Lab-
systems, Stockholm, Sweden) using 355 nm excitation and 460 nm
emission wavelengths. Fluorescence was measured every 70 s during
a 30 min period, and £uorescence units were converted to pmol of
AMC using a standard curve generated with free AMC.
2.7. DNA fragmentation
DNA fragmentation was assessed by conventional agarose gel elec-
trophoresis and £ow cytometry. For visualization of DNA laddering,
2U106 cells were washed once in PBS and resuspended in sample
bu¡er containing RNase (10 mg/ml) for 20 min at room temperature.
Cell lysates were then loaded on a 1.8% agarose gel with a digestion
gel (0.8% ultrapure agarose, 2% sodium dodecyl sulfate, 0.6 mg/ml
proteinase K) at the upper end. The gel was run at 20 V for 14 h and
then at 90 V for 2.5 h. After ethidium bromide staining, DNA was
visualized under 305 nm UV illumination. For £ow cytometric anal-
ysis, 1U106 cells were harvested, washed once in PBS and resus-
pended in staining solution containing 50 Wg/ml propidium iodide,
0.1% Triton X-100, and 0.1% sodium citrate in PBS. Cells were
then analyzed on a FACScan (Becton Dickinson) using the CellQuest
software. Data are presented as the percentage of cells displaying
hypodiploid DNA content.
2.8. Phagocytosis assays
Phagocytosis was evaluated as described elsewhere [3]. Brie£y, tar-
get cells were labeled using 50 WM of the £uorescent dye 5(6)-carboxy-
tetramethyl-rhodamine N-hydroxy-succimide ester (TAMRA) (Sigma)
in serum-free medium for 15 min at 37‡C and then cultured in the
absence or presence of the apoptotic stimulus. Target cells were
then washed twice in serum-free medium and resuspended in fresh
medium, and layered onto THP-1 or J774A.1 macrophages at a ratio
of 10:1. Cells were co-cultured for 2 h at 37‡C and non-engulfed cells
were then removed by seven or eight rounds of washing with PBS; the
remaining, adherent cells were ¢xed in 2% paraformaldehyde. Phago-
cytosis was evaluated by counting macrophages in visible light and
thereafter counting macrophage-engulfed cells under UV illumination
using a £uorescence microscope at 400U magni¢cation. At least 300
macrophages per experimental condition were scored, and data are
presented as the percentage of macrophages positive for uptake of
target cells.
2.9. Statistics
Data are expressed as meanSS.D. Samples were analyzed by Stu-
dent’s t-test (single comparisons). Di¡erences between means were
considered signi¢cant when P6 0.05.
3. Results and discussion
3.1. Bcl-2 protects against mitochondrial perturbation and
blocks PS exposure in Fas-triggered type I cells, yet fails
to prevent nuclear apoptotic changes
To address the importance of mitochondria for the exter-
nalization of PS, we utilized SKW6.4 (type I) cells stably
transfected with Bcl-2. Western blot con¢rmed a four-fold
elevation of Bcl-2 expression in the bcl-2-transfected cells as
compared to vector-transfected controls (Fig. 1A). Moreover,
Fas-induced dissipation of vim was abrogated upon overex-
Fig. 1. Bcl-2 overexpression prevents Fas-mediated mitochondrial
perturbation in SKW6.4 (type I) cells. A: Total cell lysates of
SKW6.4-neo and SKW6.4-bcl-2 cells were analyzed by Western blot
using a Bcl-2-speci¢c antibody. G3PDH was monitored to control
for equal loading of protein. B: Cells treated with agonistic anti-
Fas antibodies (250 ng/ml) in the presence or absence of the pan-
caspase inhibitor zVAD-fmk (10 WM) were assessed for loss of vim.
Data shown are expressed as meanSS.D. (n=3). *P6 0.01 (neo vs.
bcl-2).
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pression of Bcl-2, thus con¢rming that the Bcl-2 protein was,
indeed, functional (Fig. 1B). As expected, the pan-caspase
inhibitor zVAD-fmk also blocked the drop in vim. Hence,
for clari¢cation, it should be noted that mitochondrial alter-
ations, as evidenced by the decline in vim, occur in both type
I and type II cells ; however, such changes are of no conse-
quence for the induction of nuclear apoptosis in type I cells
(discussed below). We then studied the externalization of PS
following Fas stimulation. As seen in Fig. 2A, SKW6.4-bcl-2
cells exhibited signi¢cantly less PS exposure when compared
to their control-transfected counterparts. For comparison,
zVAD-fmk was found to block PS externalization completely
in both cell lines. Downstream activation of caspase-3-like
enzymes was, on the other hand, una¡ected in Bcl-2-overex-
pressing cells (data not shown). Fas-triggered DNA fragmen-
tation was also una¡ected by the overexpression of Bcl-2 (Fig.
2B,C). The latter data further support the contention [9] that
nuclear apoptotic events transpire independently of mitochon-
drial alterations in type I cells. Importantly, while Bcl-2
blocks nuclear apoptotic changes [9] and PS externalization
[15] in Fas type II cells, our data show, for the ¢rst time, that
Fas-induced PS exposure and DNA fragmentation can be
dissociated in type I cells. A lack of nuclear involvement in
the redistribution of PS has also been observed in other mod-
els of apoptosis [16^18]. Taken together, it appears that PS
externalization, both in type I and type II cells, is a Bcl-2-
inhibitable, mitochondria-dependent event.
3.2. Bcl-2 overexpression promotes mitochondrial ATP
production and prevents the decline in ATP upon
apoptosis induction
We previously identi¢ed an Epstein^Barr virus-transformed
B cell line (Raji) that undergoes apoptosis upon Fas ligation,
yet is defective for PS exposure [14]. We have also shown that
Raji cells retain normal levels of intracellular ATP upon Fas
stimulation; however, when ATP levels are suppressed, Fas
triggering results in apoptotic PS exposure in these cells [8]. In
line with these observations, basal levels of ATP in SKW6.4-
bcl-2 cells were signi¢cantly higher than in neo cells, and the
Fas-triggered dissipation of ATP was e¡ectively blocked by
Bcl-2 (Fig. 3A). To con¢rm that this e¡ect of Bcl-2 was due to
the maintenance of mitochondrial function (as opposed to a
promotion of extramitochondrial ATP production), SKW6.4-
bcl-2 and neo cells were incubated with oligomycin, an inhib-
Fig. 2. Bcl-2 overexpression blocks Fas-triggered PS exposure, but fails to prevent nuclear apoptotic changes. SKW6.4-neo and SKW6.4-bcl-2
cells were treated as detailed in the legend to Fig. 1, and assessed for (A) PS exposure, (B) DNA fragmentation, as evidenced by the degree of
hypodiploid DNA content, and (C) DNA laddering. Data shown in A and B are expressed as meanSS.D. (n=3^4). *P6 0.01, **P6 0.001
(neo vs. bcl-2). No signi¢cant di¡erences in DNA fragmentation were detected between neo and bcl-2 cells.
Fig. 3. Overexpression of Bcl-2 promotes mitochondrial ATP production. A: Intracellular ATP levels were determined in SKW6.4-neo and
SKW6.4-bcl-2 cells upon treatment with agonistic anti-Fas antibodies (250 ng/ml) for the indicated timepoints. Data are shown as meanSS.D.
(n=4). B: SKW6.4-neo and SKW6.4-bcl-2 cells were incubated for 30 min in the presence or absence of oligomycin (5 Wg/ml) and ATP levels
were determined. Data shown are expressed as meanSS.D. (n=4). *P6 0.05 (oligomycin vs. medium alone).
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itor of the mitochondrial F1F0-ATPase. Under these condi-
tions, intracellular ATP in the Bcl-2-overexpressing cell line
dropped to a level comparable to that seen in the vector-trans-
fected control (Fig. 3B). These data indicate that, in addition
to its established anti-apoptotic properties, Bcl-2 might also
have a more general role in the preservation of mitochondrial
function. Indeed, recent studies suggest that Bcl-2 can im-
prove oxidative phosphorylation through modulation of mi-
tochondrial adenine nucleotide translocation [19,20]. Further-
more, the current observations, in conjunction with our
previous ¢ndings in Raji cells [8], underscore the link between
the decline in intracellular ATP during apoptosis and the ex-
ternalization of PS, at least in the Fas model.
3.3. Bcl-2 overexpression attenuates macrophage clearance of
Fas-triggered type I cells: implications for the therapeutic
manipulation of apoptosis
We have previously shown that Fas-triggered cells that fail
to expose PS remain unengulfed when co-cultured with mac-
rophages, while PS-positive cells are readily removed, thus
serving to underscore the importance of PS exposure for
phagocytic clearance of Fas-triggered cells [3]. Since overex-
pression of Bcl-2 inhibited PS externalization in SKW6.4 cells
but not other features of apoptosis, we wished to assess
whether phagocytic recognition of these cells also was im-
paired. For this purpose, Fas-triggered SKW6.4-bcl-2 cells
and their vector-transfected counterparts were co-cultured
with THP-1 macrophages, and the degree of phagocytosis
was determined. As seen in Fig. 4A,B, Bcl-2 overexpression
signi¢cantly attenuated macrophage engulfment of SKW6.4
cells. Similar data were obtained upon co-cultivation of cells
with the murine macrophage cell line J774A.1 (Fig. 4C).
Therefore, while nuclear apoptotic alterations in Fas type I
cells are mitochondria-independent ([9] ; the present study),
the externalization of PS and subsequent recognition of cells
by macrophages appears to be governed by mitochondrial
events. Hence, although Fas-triggered SKW6.4-bcl-2 cells
are committed to death and sustain DNA fragmentation, a
classical manifestation of apoptosis, they remain functionally
‘un-dead’ since they fail to undergo macrophage clearance.
The implications of these ¢ndings for in vivo conditions are
readily apparent: if cells that are triggered to undergo apo-
ptosis escape phagocytic clearance then the ‘meaning’ of cell
death is precluded, as such cells are likely to undergo second-
ary necrosis, an event that will ultimately lead to in£amma-
tion and tissue scarring.
4. Concluding remarks
The current data indicate that the cellular manifestations of
Fas-triggered apoptosis are governed by subprograms or par-
allel processes, some of which rely on mitochondrial events
and others which are independent thereof. Speci¢cally, while
SKW6.4 cells can be classi¢ed as type I based on the mito-
chondria-independent, nuclear manifestations of apoptosis,
these cells are nevertheless mitochondria-dependent from the
Fig. 4. Bcl-2 overexpression attenuates macrophage clearance of Fas-triggered type I cells. A: Visualization of THP-1 macrophages upon co-
cultivation with apoptotic (Fas stimulation, 5 h) versus untreated SKW6.4-neo cells. Arrows indicate macrophages that have ingested TAMRA-
labeled target cells. Original magni¢cation 400U. B: Quanti¢cation of macrophage engulfment of SKW6.4-neo and SKW6.4-bcl-2 cells. The
percentages of THP-1 macrophages positive for uptake of TAMRA-labeled target cells are depicted. C: J774A.1 macrophage engulfment of tar-
get cells treated as above. Data shown in B and C are meanSS.D. (n=4). *P6 0.05 (neo vs. bcl-2).
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point of view of PS externalization and macrophage engulf-
ment. Hence, under certain circumstances, the execution phase
of apoptosis can be divorced from the resolution phase. An
increased understanding of the molecular mechanisms under-
lying both stages of cell death may aid in the design of novel
therapeutic strategies in diseases characterized by excessive or
unscheduled cell loss by apoptosis.
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